CIPROFLOXACIN AND DEXAMETHASONE Drug Patent Profile
✉ Email this page to a colleague
When do Ciprofloxacin And Dexamethasone patents expire, and what generic alternatives are available?
Ciprofloxacin And Dexamethasone is a drug marketed by Dr Reddys, Sentiss, and Sun Pharm. and is included in three NDAs.
The generic ingredient in CIPROFLOXACIN AND DEXAMETHASONE is ciprofloxacin; dexamethasone. There are thirty-four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ciprofloxacin; dexamethasone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ciprofloxacin And Dexamethasone
A generic version of CIPROFLOXACIN AND DEXAMETHASONE was approved as ciprofloxacin; dexamethasone by DR REDDYS on August 10th, 2020.
Summary for CIPROFLOXACIN AND DEXAMETHASONE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 3 |
| Clinical Trials: | 14 |
| Patent Applications: | 80 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in CIPROFLOXACIN AND DEXAMETHASONE? | CIPROFLOXACIN AND DEXAMETHASONE excipients list |
| DailyMed Link: | CIPROFLOXACIN AND DEXAMETHASONE at DailyMed |
Recent Clinical Trials for CIPROFLOXACIN AND DEXAMETHASONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Campinas, Brazil | Phase 2 |
| St. Paul's Hospital, Canada | Phase 4 |
| National University of Malaysia | Phase 1/Phase 2 |
Pharmacology for CIPROFLOXACIN AND DEXAMETHASONE
Anatomical Therapeutic Chemical (ATC) Classes for CIPROFLOXACIN AND DEXAMETHASONE
US Patents and Regulatory Information for CIPROFLOXACIN AND DEXAMETHASONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys | CIPROFLOXACIN AND DEXAMETHASONE | ciprofloxacin; dexamethasone | SUSPENSION/DROPS;OTIC | 205548-001 | Aug 10, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sentiss | CIPROFLOXACIN AND DEXAMETHASONE | ciprofloxacin; dexamethasone | SUSPENSION/DROPS;OTIC | 215768-001 | Jun 9, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sun Pharm | CIPROFLOXACIN AND DEXAMETHASONE | ciprofloxacin; dexamethasone | SUSPENSION/DROPS;OTIC | 210470-001 | Aug 30, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
